Pfizer already makes big revenues from its breast cancer drug Ibrance, but a late-stage trial failure has set back its hopes of even loftier sales – and set up a challenge from Eli Lilly’s ...

Additional 15 drugs are taken by over 5 million Americans and treat cancer, type 2 diabetes, asthma, and more WASHINGTON, D.C ...

CDK4/6 inhibitor Ibrance has been available since 2020 to patients in this group through the Cancer Drugs Fund (CDF), which allows temporary access while further evidence of a therapy's value is ...

Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...

Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

Big Pharma is again raising the prices for key medications that could save the lives of millions in Georgia and there are still more hikes to come.

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Sometimes you may receive a combination of therapies, or something else entirely. Oncology (cancer) drugs include a range of therapies and medications, such as chemotherapy drugs, targeted ...

Medicare plans to negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...